LIMK1 and pachyonychia congenita: In androgen-dependent PC patients, the LIMK1 inhibitor inhibits PC cell proliferation and migration by altering microtubule-dynamics-impeding DHT-induced androgen receptor nuclear translocation, protein stability, and transcriptional activity [202].